Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults

NCT04439695 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Low dose
BIOLOGICAL: Intermediate dose
BIOLOGICAL: High dose
BIOLOGICAL: Placebo

Sponsor

KBio Inc